 VANCOUVER and MINNEAPOLIS, Jan. 15, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- Neovasc Inc. Neovasc or the Company Nasdaq, TSX: NVCN announced today that it has received a not-approvable letter from U.S. Food Drug Administration FDA regarding its PMA submission for the Neovasc ReducerTM Reducer. 